Search all medical codes

Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; severe acute respiratory sy

CPT4 code

Name of the Procedure:

Common Name: Infectious Agent Antigen Detection
Technical Terms: Immunoassay Technique, Enzyme Immunoassay (EIA), Enzyme-Linked Immunosorbent Assay (ELISA), Immunochemiluminometric Assay (IMCA)

Summary

This procedure involves detecting the presence of specific infectious agents in a patient's body using advanced immunoassay techniques. It helps identify infectious diseases like severe acute respiratory syndrome (SARS) by analyzing patient samples for antigens related to the pathogen.

Purpose

Medical Condition: Severe Acute Respiratory Syndrome (SARS) Goals: To diagnose the presence of SARS-related pathogens accurately, enabling appropriate treatment and management of the disease.

Indications

  • Symptoms such as high fever, cough, breathing difficulties, and other respiratory issues.
  • Close contact with confirmed SARS cases or travel history to SARS-affected areas.
  • Health surveillance in outbreak situations.

Preparation

  • Patients may need to fast for a certain period before the procedure.
  • Specific instructions regarding medication intake may be provided.
  • Sometimes, preliminary diagnostic tests such as blood work or imaging might be needed.

Procedure Description

  1. Sample Collection: A sample (e.g., blood, sputum, or nasal swab) is collected from the patient.
  2. Preparation: The sample is prepared and treated to separate the relevant antigens.
  3. Application: The prepared sample is applied to a test system containing antibodies designed to bind specific antigens.
  4. Detection: The system uses enzymes or chemiluminescence to produce a detectable signal if antigens are present.
  5. Result Analysis: The results are analyzed qualitatively or semi-quantitatively to determine antigen presence.

Tools and Technology: Enzyme-linked substrates, antigen-specific antibodies, detection reagents. Anesthesia: Not applicable.

Duration

Typically completed within a few hours, though this can vary depending on the sample type and testing facility.

Setting

Performed in specialized laboratories within hospitals or diagnostic centers.

Personnel

  • Laboratory Technicians
  • Immunologists
  • Pathologists

Risks and Complications

  • Minimal risk associated with sample collection (e.g., slight discomfort or minor bleeding).
  • Rarely, incorrect sample handling could lead to inaccurate results.

Benefits

  • Rapid and accurate diagnosis of SARS.
  • Early detection allows timely and appropriate treatment, reducing disease spread.
  • Insights into the patient's immune response to the infectious agent.

Recovery

  • Post-sample collection care is minimal (e.g., applying pressure on the collection site).
  • Most patients can resume normal activities immediately.
  • Follow-up appointments as necessary based on results.

Alternatives

  • Polymerase Chain Reaction (PCR): High accuracy but more complex and time-consuming.
  • Clinical Diagnosis: Based on symptoms and imaging but less specific.
  • Culture Methods: Often used but slower and requires specialized facilities.

Patient Experience

  • Sample collection might cause minor discomfort.
  • Generally, the procedure is quick with minimal physical impact.
  • Any pain or discomfort is manageable and resolves quickly.

Medical Policies and Guidelines for Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; severe acute respiratory sy

Related policies from health plans

Similar Codes